+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)
Neuropathy Pain Treatment Market by Treatment Type (Complementary, Device, Drug), Route Of Administration (Injectable, Oral, Topical), Distribution Channel, End User - Global Forecast 2025-2030- Product Image
Neuropathy Pain Treatment Market by Treatment Type (Complementary, Device, Drug), Route Of Administration (Injectable, Oral, Topical), Distribution Channel, End User - Global Forecast 2025-2030- Product Image
Sale

Neuropathy Pain Treatment Market by Treatment Type (Complementary, Device, Drug), Route Of Administration (Injectable, Oral, Topical), Distribution Channel, End User - Global Forecast 2025-2030

  • PDF Icon

    Report

  • 186 Pages
  • August 2025
  • Region: Global
  • 360iResearch™
  • ID: 5666258
UP TO OFF until Jan 01st 2026
1h Free Analyst Time
Description Jump to:
1h Free Analyst Time

Speak directly to the analyst to clarify any post sales queries you may have.

The neuropathy pain treatment market is undergoing significant transformation as healthcare systems prioritize patient-centered care and technological innovation. Evolving therapeutic landscapes, multidisciplinary collaboration, and data-driven strategies are shaping a more integrated and adaptive approach to managing chronic neuropathic pain—driving opportunity for those prepared to lead in this sector.

Market Snapshot: Neuropathy Pain Treatment Market Growth

The neuropathy pain treatment market grew from USD 8.59 billion in 2024 to USD 9.64 billion in 2025. The sector is projected to expand further at a CAGR of 11.63%, reaching USD 16.63 billion by 2030. This robust market trajectory highlights persistent unmet needs, increased technology adoption, and rising global prevalence of neuropathic pain across key demographic and regional groups. The combination of innovative medicine, next-generation devices, and integrative care models positions this market for notable evolution and investment attractiveness among industry stakeholders.

Scope & Segmentation of the Neuropathy Pain Treatment Market

This report delivers an in-depth strategic analysis, encompassing critical dimensions of the neuropathy pain treatment market. Key segmentation areas include:

  • Treatment Type: Complementary (herbal supplements, mind-body techniques), devices (neuromodulation, TENS), drugs (analgesics, anticonvulsants, antidepressants, topical agents), therapies (acupuncture, massage therapy, physical therapy).
  • Route of Administration: Injectable (intravenous, subcutaneous), oral (capsules, tablets), topical (creams, gels), and transdermal (patches).
  • Distribution Channel: Hospital pharmacies, online pharmacies, retail pharmacies, specialty clinics.
  • End User: Ambulatory care, clinics, home care, hospitals.
  • Geographical Regions: Americas (notably the United States, Canada, Mexico, Brazil, Argentina), Europe, Middle East & Africa (including the United Kingdom, Germany, France, and key emerging markets), Asia-Pacific (such as China, India, Japan, Australia, and others).
  • Leading Companies: Pfizer Inc., Eli Lilly and Company, Teva Pharmaceutical Industries Ltd., Viatris Inc., Endo International plc, Grünenthal GmbH, Novartis AG, Astellas Pharma Inc., Sun Pharmaceutical Industries Ltd., Sandoz International GmbH.
  • Technological Adoption: Includes neuromodulation devices, targeted drug delivery, telehealth platforms, wearable technologies, and digital therapeutics.

Key Takeaways for Senior Decision-Makers

  • Comprehensive, multimodal approaches—spanning from nonpharmacological techniques to advanced device and drug interventions—are enabling greater customization in therapy and supporting differentiated patient outcomes.
  • Increasing focus on precision medicine, leveraging digital health solutions, accelerates the integration of individualized care pathways and remote monitoring within neurology and pain management practices.
  • Stakeholder collaboration across clinical, regulatory, and commercial domains enables streamlined care delivery, expanded patient access, and a more agile response to emerging challenges in neuropathy pain management.
  • Data-driven insight and real-world evidence gathered through digital therapeutics and interdisciplinary partnerships are driving more informed product development, clinician decision-making, and reimbursement strategy alignment.
  • Regional adaptation remains crucial, as infrastructure, regulatory frameworks, and patient access differ considerably across developed and emerging markets, influencing both uptake and innovation pathways.

Tariff Impact: Navigating Cost Shifts in Global Supply Chains

Recent United States tariffs have introduced new challenges and cost pressures within neuropathy pain treatment supply chains, affecting key imported components and pharmaceutical ingredients. Manufacturers are responding with strategic sourcing shifts, nearshoring, and vertical integration to preserve operational resilience and maintain patient affordability, while closely collaborating with regulatory bodies to support equitable access.

Methodology & Data Sources

This report is grounded in a rigorous hybrid research methodology. Secondary research—covering scientific literature, clinical trials, regulatory filings, and industry publications—provided foundational insight. Primary research included interviews with neurologists, device engineers, and health economics experts. Findings were validated by a Delphi panel and enriched through data triangulation and peer reviews for reliability and transparency.

Why This Report Matters for the Neuropathy Pain Treatment Market

  • Enables strategic planning by clarifying the full competitive landscape, technological innovation trends, and evolving distribution channels.
  • Supports risk management and investment decisions through actionable analysis of regional variations, tariff implications, and regulatory challenges.
  • Provides stakeholders with the insights needed to align product development, market entry, and clinical adoption with shifting patient and provider needs worldwide.

Conclusion

The neuropathy pain treatment market is rapidly evolving, shaped by innovation, collaboration, and shifting patient expectations. Organizations prepared to embrace interdisciplinary care models and operational agility will be best positioned for sustained growth and improved patient outcomes in this dynamic environment.

 

Additional Product Information:

  • Purchase of this report includes 1 year online access with quarterly updates.
  • This report can be updated on request. Please contact our Customer Experience team using the Ask a Question widget on our website.

Table of Contents

1. Preface
1.1. Objectives of the Study
1.2. Market Segmentation & Coverage
1.3. Years Considered for the Study
1.4. Currency & Pricing
1.5. Language
1.6. Stakeholders
2. Research Methodology
2.1. Define: Research Objective
2.2. Determine: Research Design
2.3. Prepare: Research Instrument
2.4. Collect: Data Source
2.5. Analyze: Data Interpretation
2.6. Formulate: Data Verification
2.7. Publish: Research Report
2.8. Repeat: Report Update
3. Executive Summary
4. Market Overview
4.1. Introduction
4.2. Market Sizing & Forecasting
5. Market Dynamics
5.1. Integration of neuromodulation devices with AI-driven pain tracking for personalized neuropathy management
5.2. Expansion of topical analgesic formulations using novel nanocarrier systems for enhanced targeted neuropathy relief
5.3. Emergence of peptide-based biologics targeting neuroinflammation pathways to alleviate chronic neuropathic pain symptoms
5.4. Growing adoption of wearable biosensors coupled with real-time patient feedback to optimize neuropathy treatment regimens
5.5. Regulatory approval of generic high-concentration capsaicin patches influencing cost dynamics in neuropathic pain care
5.6. Rising investment in cannabinoid-derived pharmacotherapies for peripheral neuropathy pain management trials
5.7. Integration of telemedicine platforms with digital pain diaries to improve long-term neuropathy patient outcomes
6. Market Insights
6.1. Porter’s Five Forces Analysis
6.2. PESTLE Analysis
7. Cumulative Impact of United States Tariffs 2025
8. Neuropathy Pain Treatment Market, by Treatment Type
8.1. Introduction
8.2. Complementary
8.2.1. Herbal Supplements
8.2.2. Mind Body Techniques
8.3. Device
8.3.1. Neuromodulation
8.3.1.1. Peripheral Nerve Stimulation
8.3.1.2. Spinal Cord Stimulation
8.3.2. TENS
8.4. Drug
8.4.1. Analgesics
8.4.1.1. Non-Opioids
8.4.1.2. Opioids
8.4.2. Anticonvulsants
8.4.2.1. Gabapentinoids
8.4.3. Antidepressants
8.4.3.1. SNRIs
8.4.3.2. TCAs
8.4.4. Topical Agents
8.4.4.1. Capsaicin
8.4.4.2. Lidocaine
8.5. Therapy
8.5.1. Acupuncture
8.5.2. Massage Therapy
8.5.3. Physical Therapy
9. Neuropathy Pain Treatment Market, by Route Of Administration
9.1. Introduction
9.2. Injectable
9.2.1. Intravenous
9.2.2. Subcutaneous
9.3. Oral
9.3.1. Capsules
9.3.2. Tablets
9.4. Topical
9.4.1. Creams
9.4.2. Gels
9.5. Transdermal
9.5.1. Patches
10. Neuropathy Pain Treatment Market, by Distribution Channel
10.1. Introduction
10.2. Hospital Pharmacy
10.3. Online Pharmacy
10.4. Retail Pharmacy
10.5. Specialty Clinic
11. Neuropathy Pain Treatment Market, by End User
11.1. Introduction
11.2. Ambulatory Care
11.3. Clinic
11.4. Home Care
11.5. Hospital
12. Americas Neuropathy Pain Treatment Market
12.1. Introduction
12.2. United States
12.3. Canada
12.4. Mexico
12.5. Brazil
12.6. Argentina
13. Europe, Middle East & Africa Neuropathy Pain Treatment Market
13.1. Introduction
13.2. United Kingdom
13.3. Germany
13.4. France
13.5. Russia
13.6. Italy
13.7. Spain
13.8. United Arab Emirates
13.9. Saudi Arabia
13.10. South Africa
13.11. Denmark
13.12. Netherlands
13.13. Qatar
13.14. Finland
13.15. Sweden
13.16. Nigeria
13.17. Egypt
13.18. Turkey
13.19. Israel
13.20. Norway
13.21. Poland
13.22. Switzerland
14. Asia-Pacific Neuropathy Pain Treatment Market
14.1. Introduction
14.2. China
14.3. India
14.4. Japan
14.5. Australia
14.6. South Korea
14.7. Indonesia
14.8. Thailand
14.9. Philippines
14.10. Malaysia
14.11. Singapore
14.12. Vietnam
14.13. Taiwan
15. Competitive Landscape
15.1. Market Share Analysis, 2024
15.2. FPNV Positioning Matrix, 2024
15.3. Competitive Analysis
15.3.1. Pfizer Inc.
15.3.2. Eli Lilly and Company
15.3.3. Teva Pharmaceutical Industries Ltd.
15.3.4. Viatris Inc.
15.3.5. Endo International plc
15.3.6. Grünenthal GmbH
15.3.7. Novartis AG
15.3.8. Astellas Pharma Inc.
15.3.9. Sun Pharmaceutical Industries Ltd.
15.3.10. Sandoz International GmbH
16. ResearchAI
17. ResearchStatistics
18. ResearchContacts
19. ResearchArticles
20. Appendix
List of Figures
FIGURE 1. NEUROPATHY PAIN TREATMENT MARKET RESEARCH PROCESS
FIGURE 2. GLOBAL NEUROPATHY PAIN TREATMENT MARKET SIZE, 2018-2030 (USD MILLION)
FIGURE 3. GLOBAL NEUROPATHY PAIN TREATMENT MARKET SIZE, BY REGION, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 4. GLOBAL NEUROPATHY PAIN TREATMENT MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 5. GLOBAL NEUROPATHY PAIN TREATMENT MARKET SIZE, BY TREATMENT TYPE, 2024 VS 2030 (%)
FIGURE 6. GLOBAL NEUROPATHY PAIN TREATMENT MARKET SIZE, BY TREATMENT TYPE, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 7. GLOBAL NEUROPATHY PAIN TREATMENT MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2024 VS 2030 (%)
FIGURE 8. GLOBAL NEUROPATHY PAIN TREATMENT MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 9. GLOBAL NEUROPATHY PAIN TREATMENT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2024 VS 2030 (%)
FIGURE 10. GLOBAL NEUROPATHY PAIN TREATMENT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 11. GLOBAL NEUROPATHY PAIN TREATMENT MARKET SIZE, BY END USER, 2024 VS 2030 (%)
FIGURE 12. GLOBAL NEUROPATHY PAIN TREATMENT MARKET SIZE, BY END USER, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 13. AMERICAS NEUROPATHY PAIN TREATMENT MARKET SIZE, BY COUNTRY, 2024 VS 2030 (%)
FIGURE 14. AMERICAS NEUROPATHY PAIN TREATMENT MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 15. UNITED STATES NEUROPATHY PAIN TREATMENT MARKET SIZE, BY STATE, 2024 VS 2030 (%)
FIGURE 16. UNITED STATES NEUROPATHY PAIN TREATMENT MARKET SIZE, BY STATE, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 17. EUROPE, MIDDLE EAST & AFRICA NEUROPATHY PAIN TREATMENT MARKET SIZE, BY COUNTRY, 2024 VS 2030 (%)
FIGURE 18. EUROPE, MIDDLE EAST & AFRICA NEUROPATHY PAIN TREATMENT MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 19. ASIA-PACIFIC NEUROPATHY PAIN TREATMENT MARKET SIZE, BY COUNTRY, 2024 VS 2030 (%)
FIGURE 20. ASIA-PACIFIC NEUROPATHY PAIN TREATMENT MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 21. NEUROPATHY PAIN TREATMENT MARKET SHARE, BY KEY PLAYER, 2024
FIGURE 22. NEUROPATHY PAIN TREATMENT MARKET, FPNV POSITIONING MATRIX, 2024
FIGURE 23. NEUROPATHY PAIN TREATMENT MARKET: RESEARCHAI
FIGURE 24. NEUROPATHY PAIN TREATMENT MARKET: RESEARCHSTATISTICS
FIGURE 25. NEUROPATHY PAIN TREATMENT MARKET: RESEARCHCONTACTS
FIGURE 26. NEUROPATHY PAIN TREATMENT MARKET: RESEARCHARTICLES
List of Tables
TABLE 1. NEUROPATHY PAIN TREATMENT MARKET SEGMENTATION & COVERAGE
TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2024
TABLE 3. GLOBAL NEUROPATHY PAIN TREATMENT MARKET SIZE, 2018-2024 (USD MILLION)
TABLE 4. GLOBAL NEUROPATHY PAIN TREATMENT MARKET SIZE, 2025-2030 (USD MILLION)
TABLE 5. GLOBAL NEUROPATHY PAIN TREATMENT MARKET SIZE, BY REGION, 2018-2024 (USD MILLION)
TABLE 6. GLOBAL NEUROPATHY PAIN TREATMENT MARKET SIZE, BY REGION, 2025-2030 (USD MILLION)
TABLE 7. GLOBAL NEUROPATHY PAIN TREATMENT MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
TABLE 8. GLOBAL NEUROPATHY PAIN TREATMENT MARKET SIZE, BY COUNTRY, 2025-2030 (USD MILLION)
TABLE 9. GLOBAL NEUROPATHY PAIN TREATMENT MARKET SIZE, BY TREATMENT TYPE, 2018-2024 (USD MILLION)
TABLE 10. GLOBAL NEUROPATHY PAIN TREATMENT MARKET SIZE, BY TREATMENT TYPE, 2025-2030 (USD MILLION)
TABLE 11. GLOBAL NEUROPATHY PAIN TREATMENT MARKET SIZE, BY COMPLEMENTARY, BY REGION, 2018-2024 (USD MILLION)
TABLE 12. GLOBAL NEUROPATHY PAIN TREATMENT MARKET SIZE, BY COMPLEMENTARY, BY REGION, 2025-2030 (USD MILLION)
TABLE 13. GLOBAL NEUROPATHY PAIN TREATMENT MARKET SIZE, BY HERBAL SUPPLEMENTS, BY REGION, 2018-2024 (USD MILLION)
TABLE 14. GLOBAL NEUROPATHY PAIN TREATMENT MARKET SIZE, BY HERBAL SUPPLEMENTS, BY REGION, 2025-2030 (USD MILLION)
TABLE 15. GLOBAL NEUROPATHY PAIN TREATMENT MARKET SIZE, BY MIND BODY TECHNIQUES, BY REGION, 2018-2024 (USD MILLION)
TABLE 16. GLOBAL NEUROPATHY PAIN TREATMENT MARKET SIZE, BY MIND BODY TECHNIQUES, BY REGION, 2025-2030 (USD MILLION)
TABLE 17. GLOBAL NEUROPATHY PAIN TREATMENT MARKET SIZE, BY COMPLEMENTARY, 2018-2024 (USD MILLION)
TABLE 18. GLOBAL NEUROPATHY PAIN TREATMENT MARKET SIZE, BY COMPLEMENTARY, 2025-2030 (USD MILLION)
TABLE 19. GLOBAL NEUROPATHY PAIN TREATMENT MARKET SIZE, BY DEVICE, BY REGION, 2018-2024 (USD MILLION)
TABLE 20. GLOBAL NEUROPATHY PAIN TREATMENT MARKET SIZE, BY DEVICE, BY REGION, 2025-2030 (USD MILLION)
TABLE 21. GLOBAL NEUROPATHY PAIN TREATMENT MARKET SIZE, BY NEUROMODULATION, BY REGION, 2018-2024 (USD MILLION)
TABLE 22. GLOBAL NEUROPATHY PAIN TREATMENT MARKET SIZE, BY NEUROMODULATION, BY REGION, 2025-2030 (USD MILLION)
TABLE 23. GLOBAL NEUROPATHY PAIN TREATMENT MARKET SIZE, BY PERIPHERAL NERVE STIMULATION, BY REGION, 2018-2024 (USD MILLION)
TABLE 24. GLOBAL NEUROPATHY PAIN TREATMENT MARKET SIZE, BY PERIPHERAL NERVE STIMULATION, BY REGION, 2025-2030 (USD MILLION)
TABLE 25. GLOBAL NEUROPATHY PAIN TREATMENT MARKET SIZE, BY SPINAL CORD STIMULATION, BY REGION, 2018-2024 (USD MILLION)
TABLE 26. GLOBAL NEUROPATHY PAIN TREATMENT MARKET SIZE, BY SPINAL CORD STIMULATION, BY REGION, 2025-2030 (USD MILLION)
TABLE 27. GLOBAL NEUROPATHY PAIN TREATMENT MARKET SIZE, BY NEUROMODULATION, 2018-2024 (USD MILLION)
TABLE 28. GLOBAL NEUROPATHY PAIN TREATMENT MARKET SIZE, BY NEUROMODULATION, 2025-2030 (USD MILLION)
TABLE 29. GLOBAL NEUROPATHY PAIN TREATMENT MARKET SIZE, BY TENS, BY REGION, 2018-2024 (USD MILLION)
TABLE 30. GLOBAL NEUROPATHY PAIN TREATMENT MARKET SIZE, BY TENS, BY REGION, 2025-2030 (USD MILLION)
TABLE 31. GLOBAL NEUROPATHY PAIN TREATMENT MARKET SIZE, BY DEVICE, 2018-2024 (USD MILLION)
TABLE 32. GLOBAL NEUROPATHY PAIN TREATMENT MARKET SIZE, BY DEVICE, 2025-2030 (USD MILLION)
TABLE 33. GLOBAL NEUROPATHY PAIN TREATMENT MARKET SIZE, BY DRUG, BY REGION, 2018-2024 (USD MILLION)
TABLE 34. GLOBAL NEUROPATHY PAIN TREATMENT MARKET SIZE, BY DRUG, BY REGION, 2025-2030 (USD MILLION)
TABLE 35. GLOBAL NEUROPATHY PAIN TREATMENT MARKET SIZE, BY ANALGESICS, BY REGION, 2018-2024 (USD MILLION)
TABLE 36. GLOBAL NEUROPATHY PAIN TREATMENT MARKET SIZE, BY ANALGESICS, BY REGION, 2025-2030 (USD MILLION)
TABLE 37. GLOBAL NEUROPATHY PAIN TREATMENT MARKET SIZE, BY NON-OPIOIDS, BY REGION, 2018-2024 (USD MILLION)
TABLE 38. GLOBAL NEUROPATHY PAIN TREATMENT MARKET SIZE, BY NON-OPIOIDS, BY REGION, 2025-2030 (USD MILLION)
TABLE 39. GLOBAL NEUROPATHY PAIN TREATMENT MARKET SIZE, BY OPIOIDS, BY REGION, 2018-2024 (USD MILLION)
TABLE 40. GLOBAL NEUROPATHY PAIN TREATMENT MARKET SIZE, BY OPIOIDS, BY REGION, 2025-2030 (USD MILLION)
TABLE 41. GLOBAL NEUROPATHY PAIN TREATMENT MARKET SIZE, BY ANALGESICS, 2018-2024 (USD MILLION)
TABLE 42. GLOBAL NEUROPATHY PAIN TREATMENT MARKET SIZE, BY ANALGESICS, 2025-2030 (USD MILLION)
TABLE 43. GLOBAL NEUROPATHY PAIN TREATMENT MARKET SIZE, BY ANTICONVULSANTS, BY REGION, 2018-2024 (USD MILLION)
TABLE 44. GLOBAL NEUROPATHY PAIN TREATMENT MARKET SIZE, BY ANTICONVULSANTS, BY REGION, 2025-2030 (USD MILLION)
TABLE 45. GLOBAL NEUROPATHY PAIN TREATMENT MARKET SIZE, BY GABAPENTINOIDS, BY REGION, 2018-2024 (USD MILLION)
TABLE 46. GLOBAL NEUROPATHY PAIN TREATMENT MARKET SIZE, BY GABAPENTINOIDS, BY REGION, 2025-2030 (USD MILLION)
TABLE 47. GLOBAL NEUROPATHY PAIN TREATMENT MARKET SIZE, BY ANTICONVULSANTS, 2018-2024 (USD MILLION)
TABLE 48. GLOBAL NEUROPATHY PAIN TREATMENT MARKET SIZE, BY ANTICONVULSANTS, 2025-2030 (USD MILLION)
TABLE 49. GLOBAL NEUROPATHY PAIN TREATMENT MARKET SIZE, BY ANTIDEPRESSANTS, BY REGION, 2018-2024 (USD MILLION)
TABLE 50. GLOBAL NEUROPATHY PAIN TREATMENT MARKET SIZE, BY ANTIDEPRESSANTS, BY REGION, 2025-2030 (USD MILLION)
TABLE 51. GLOBAL NEUROPATHY PAIN TREATMENT MARKET SIZE, BY SNRIS, BY REGION, 2018-2024 (USD MILLION)
TABLE 52. GLOBAL NEUROPATHY PAIN TREATMENT MARKET SIZE, BY SNRIS, BY REGION, 2025-2030 (USD MILLION)
TABLE 53. GLOBAL NEUROPATHY PAIN TREATMENT MARKET SIZE, BY TCAS, BY REGION, 2018-2024 (USD MILLION)
TABLE 54. GLOBAL NEUROPATHY PAIN TREATMENT MARKET SIZE, BY TCAS, BY REGION, 2025-2030 (USD MILLION)
TABLE 55. GLOBAL NEUROPATHY PAIN TREATMENT MARKET SIZE, BY ANTIDEPRESSANTS, 2018-2024 (USD MILLION)
TABLE 56. GLOBAL NEUROPATHY PAIN TREATMENT MARKET SIZE, BY ANTIDEPRESSANTS, 2025-2030 (USD MILLION)
TABLE 57. GLOBAL NEUROPATHY PAIN TREATMENT MARKET SIZE, BY TOPICAL AGENTS, BY REGION, 2018-2024 (USD MILLION)
TABLE 58. GLOBAL NEUROPATHY PAIN TREATMENT MARKET SIZE, BY TOPICAL AGENTS, BY REGION, 2025-2030 (USD MILLION)
TABLE 59. GLOBAL NEUROPATHY PAIN TREATMENT MARKET SIZE, BY CAPSAICIN, BY REGION, 2018-2024 (USD MILLION)
TABLE 60. GLOBAL NEUROPATHY PAIN TREATMENT MARKET SIZE, BY CAPSAICIN, BY REGION, 2025-2030 (USD MILLION)
TABLE 61. GLOBAL NEUROPATHY PAIN TREATMENT MARKET SIZE, BY LIDOCAINE, BY REGION, 2018-2024 (USD MILLION)
TABLE 62. GLOBAL NEUROPATHY PAIN TREATMENT MARKET SIZE, BY LIDOCAINE, BY REGION, 2025-2030 (USD MILLION)
TABLE 63. GLOBAL NEUROPATHY PAIN TREATMENT MARKET SIZE, BY TOPICAL AGENTS, 2018-2024 (USD MILLION)
TABLE 64. GLOBAL NEUROPATHY PAIN TREATMENT MARKET SIZE, BY TOPICAL AGENTS, 2025-2030 (USD MILLION)
TABLE 65. GLOBAL NEUROPATHY PAIN TREATMENT MARKET SIZE, BY DRUG, 2018-2024 (USD MILLION)
TABLE 66. GLOBAL NEUROPATHY PAIN TREATMENT MARKET SIZE, BY DRUG, 2025-2030 (USD MILLION)
TABLE 67. GLOBAL NEUROPATHY PAIN TREATMENT MARKET SIZE, BY THERAPY, BY REGION, 2018-2024 (USD MILLION)
TABLE 68. GLOBAL NEUROPATHY PAIN TREATMENT MARKET SIZE, BY THERAPY, BY REGION, 2025-2030 (USD MILLION)
TABLE 69. GLOBAL NEUROPATHY PAIN TREATMENT MARKET SIZE, BY ACUPUNCTURE, BY REGION, 2018-2024 (USD MILLION)
TABLE 70. GLOBAL NEUROPATHY PAIN TREATMENT MARKET SIZE, BY ACUPUNCTURE, BY REGION, 2025-2030 (USD MILLION)
TABLE 71. GLOBAL NEUROPATHY PAIN TREATMENT MARKET SIZE, BY MASSAGE THERAPY, BY REGION, 2018-2024 (USD MILLION)
TABLE 72. GLOBAL NEUROPATHY PAIN TREATMENT MARKET SIZE, BY MASSAGE THERAPY, BY REGION, 2025-2030 (USD MILLION)
TABLE 73. GLOBAL NEUROPATHY PAIN TREATMENT MARKET SIZE, BY PHYSICAL THERAPY, BY REGION, 2018-2024 (USD MILLION)
TABLE 74. GLOBAL NEUROPATHY PAIN TREATMENT MARKET SIZE, BY PHYSICAL THERAPY, BY REGION, 2025-2030 (USD MILLION)
TABLE 75. GLOBAL NEUROPATHY PAIN TREATMENT MARKET SIZE, BY THERAPY, 2018-2024 (USD MILLION)
TABLE 76. GLOBAL NEUROPATHY PAIN TREATMENT MARKET SIZE, BY THERAPY, 2025-2030 (USD MILLION)
TABLE 77. GLOBAL NEUROPATHY PAIN TREATMENT MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2024 (USD MILLION)
TABLE 78. GLOBAL NEUROPATHY PAIN TREATMENT MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2025-2030 (USD MILLION)
TABLE 79. GLOBAL NEUROPATHY PAIN TREATMENT MARKET SIZE, BY INJECTABLE, BY REGION, 2018-2024 (USD MILLION)
TABLE 80. GLOBAL NEUROPATHY PAIN TREATMENT MARKET SIZE, BY INJECTABLE, BY REGION, 2025-2030 (USD MILLION)
TABLE 81. GLOBAL NEUROPATHY PAIN TREATMENT MARKET SIZE, BY INTRAVENOUS, BY REGION, 2018-2024 (USD MILLION)
TABLE 82. GLOBAL NEUROPATHY PAIN TREATMENT MARKET SIZE, BY INTRAVENOUS, BY REGION, 2025-2030 (USD MILLION)
TABLE 83. GLOBAL NEUROPATHY PAIN TREATMENT MARKET SIZE, BY SUBCUTANEOUS, BY REGION, 2018-2024 (USD MILLION)
TABLE 84. GLOBAL NEUROPATHY PAIN TREATMENT MARKET SIZE, BY SUBCUTANEOUS, BY REGION, 2025-2030 (USD MILLION)
TABLE 85. GLOBAL NEUROPATHY PAIN TREATMENT MARKET SIZE, BY INJECTABLE, 2018-2024 (USD MILLION)
TABLE 86. GLOBAL NEUROPATHY PAIN TREATMENT MARKET SIZE, BY INJECTABLE, 2025-2030 (USD MILLION)
TABLE 87. GLOBAL NEUROPATHY PAIN TREATMENT MARKET SIZE, BY ORAL, BY REGION, 2018-2024 (USD MILLION)
TABLE 88. GLOBAL NEUROPATHY PAIN TREATMENT MARKET SIZE, BY ORAL, BY REGION, 2025-2030 (USD MILLION)
TABLE 89. GLOBAL NEUROPATHY PAIN TREATMENT MARKET SIZE, BY CAPSULES, BY REGION, 2018-2024 (USD MILLION)
TABLE 90. GLOBAL NEUROPATHY PAIN TREATMENT MARKET SIZE, BY CAPSULES, BY REGION, 2025-2030 (USD MILLION)
TABLE 91. GLOBAL NEUROPATHY PAIN TREATMENT MARKET SIZE, BY TABLETS, BY REGION, 2018-2024 (USD MILLION)
TABLE 92. GLOBAL NEUROPATHY PAIN TREATMENT MARKET SIZE, BY TABLETS, BY REGION, 2025-2030 (USD MILLION)
TABLE 93. GLOBAL NEUROPATHY PAIN TREATMENT MARKET SIZE, BY ORAL, 2018-2024 (USD MILLION)
TABLE 94. GLOBAL NEUROPATHY PAIN TREATMENT MARKET SIZE, BY ORAL, 2025-2030 (USD MILLION)
TABLE 95. GLOBAL NEUROPATHY PAIN TREATMENT MARKET SIZE, BY TOPICAL, BY REGION, 2018-2024 (USD MILLION)
TABLE 96. GLOBAL NEUROPATHY PAIN TREATMENT MARKET SIZE, BY TOPICAL, BY REGION, 2025-2030 (USD MILLION)
TABLE 97. GLOBAL NEUROPATHY PAIN TREATMENT MARKET SIZE, BY CREAMS, BY REGION, 2018-2024 (USD MILLION)
TABLE 98. GLOBAL NEUROPATHY PAIN TREATMENT MARKET SIZE, BY CREAMS, BY REGION, 2025-2030 (USD MILLION)
TABLE 99. GLOBAL NEUROPATHY PAIN TREATMENT MARKET SIZE, BY GELS, BY REGION, 2018-2024 (USD MILLION)
TABLE 100. GLOBAL NEUROPATHY PAIN TREATMENT MARKET SIZE, BY GELS, BY REGION, 2025-2030 (USD MILLION)
TABLE 101. GLOBAL NEUROPATHY PAIN TREATMENT MARKET SIZE, BY TOPICAL, 2018-2024 (USD MILLION)
TABLE 102. GLOBAL NEUROPATHY PAIN TREATMENT MARKET SIZE, BY TOPICAL, 2025-2030 (USD MILLION)
TABLE 103. GLOBAL NEUROPATHY PAIN TREATMENT MARKET SIZE, BY TRANSDERMAL, BY REGION, 2018-2024 (USD MILLION)
TABLE 104. GLOBAL NEUROPATHY PAIN TREATMENT MARKET SIZE, BY TRANSDERMAL, BY REGION, 2025-2030 (USD MILLION)
TABLE 105. GLOBAL NEUROPATHY PAIN TREATMENT MARKET SIZE, BY PATCHES, BY REGION, 2018-2024 (USD MILLION)
TABLE 106. GLOBAL NEUROPATHY PAIN TREATMENT MARKET SIZE, BY PATCHES, BY REGION, 2025-2030 (USD MILLION)
TABLE 107. GLOBAL NEUROPATHY PAIN TREATMENT MARKET SIZE, BY TRANSDERMAL, 2018-2024 (USD MILLION)
TABLE 108. GLOBAL NEUROPATHY PAIN TREATMENT MARKET SIZE, BY TRANSDERMAL, 2025-2030 (USD MILLION)
TABLE 109. GLOBAL NEUROPATHY PAIN TREATMENT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 110. GLOBAL NEUROPATHY PAIN TREATMENT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 111. GLOBAL NEUROPATHY PAIN TREATMENT MARKET SIZE, BY HOSPITAL PHARMACY, BY REGION, 2018-2024 (USD MILLION)
TABLE 112. GLOBAL NEUROPATHY PAIN TREATMENT MARKET SIZE, BY HOSPITAL PHARMACY, BY REGION, 2025-2030 (USD MILLION)
TABLE 113. GLOBAL NEUROPATHY PAIN TREATMENT MARKET SIZE, BY ONLINE PHARMACY, BY REGION, 2018-2024 (USD MILLION)
TABLE 114. GLOBAL NEUROPATHY PAIN TREATMENT MARKET SIZE, BY ONLINE PHARMACY, BY REGION, 2025-2030 (USD MILLION)
TABLE 115. GLOBAL NEUROPATHY PAIN TREATMENT MARKET SIZE, BY RETAIL PHARMACY, BY REGION, 2018-2024 (USD MILLION)
TABLE 116. GLOBAL NEUROPATHY PAIN TREATMENT MARKET SIZE, BY RETAIL PHARMACY, BY REGION, 2025-2030 (USD MILLION)
TABLE 117. GLOBAL NEUROPATHY PAIN TREATMENT MARKET SIZE, BY SPECIALTY CLINIC, BY REGION, 2018-2024 (USD MILLION)
TABLE 118. GLOBAL NEUROPATHY PAIN TREATMENT MARKET SIZE, BY SPECIALTY CLINIC, BY REGION, 2025-2030 (USD MILLION)
TABLE 119. GLOBAL NEUROPATHY PAIN TREATMENT MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 120. GLOBAL NEUROPATHY PAIN TREATMENT MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 121. GLOBAL NEUROPATHY PAIN TREATMENT MARKET SIZE, BY AMBULATORY CARE, BY REGION, 2018-2024 (USD MILLION)
TABLE 122. GLOBAL NEUROPATHY PAIN TREATMENT MARKET SIZE, BY AMBULATORY CARE, BY REGION, 2025-2030 (USD MILLION)
TABLE 123. GLOBAL NEUROPATHY PAIN TREATMENT MARKET SIZE, BY CLINIC, BY REGION, 2018-2024 (USD MILLION)
TABLE 124. GLOBAL NEUROPATHY PAIN TREATMENT MARKET SIZE, BY CLINIC, BY REGION, 2025-2030 (USD MILLION)
TABLE 125. GLOBAL NEUROPATHY PAIN TREATMENT MARKET SIZE, BY HOME CARE, BY REGION, 2018-2024 (USD MILLION)
TABLE 126. GLOBAL NEUROPATHY PAIN TREATMENT MARKET SIZE, BY HOME CARE, BY REGION, 2025-2030 (USD MILLION)
TABLE 127. GLOBAL NEUROPATHY PAIN TREATMENT MARKET SIZE, BY HOSPITAL, BY REGION, 2018-2024 (USD MILLION)
TABLE 128. GLOBAL NEUROPATHY PAIN TREATMENT MARKET SIZE, BY HOSPITAL, BY REGION, 2025-2030 (USD MILLION)
TABLE 129. AMERICAS NEUROPATHY PAIN TREATMENT MARKET SIZE, BY TREATMENT TYPE, 2018-2024 (USD MILLION)
TABLE 130. AMERICAS NEUROPATHY PAIN TREATMENT MARKET SIZE, BY TREATMENT TYPE, 2025-2030 (USD MILLION)
TABLE 131. AMERICAS NEUROPATHY PAIN TREATMENT MARKET SIZE, BY COMPLEMENTARY, 2018-2024 (USD MILLION)
TABLE 132. AMERICAS NEUROPATHY PAIN TREATMENT MARKET SIZE, BY COMPLEMENTARY, 2025-2030 (USD MILLION)
TABLE 133. AMERICAS NEUROPATHY PAIN TREATMENT MARKET SIZE, BY DEVICE, 2018-2024 (USD MILLION)
TABLE 134. AMERICAS NEUROPATHY PAIN TREATMENT MARKET SIZE, BY DEVICE, 2025-2030 (USD MILLION)
TABLE 135. AMERICAS NEUROPATHY PAIN TREATMENT MARKET SIZE, BY NEUROMODULATION, 2018-2024 (USD MILLION)
TABLE 136. AMERICAS NEUROPATHY PAIN TREATMENT MARKET SIZE, BY NEUROMODULATION, 2025-2030 (USD MILLION)
TABLE 137. AMERICAS NEUROPATHY PAIN TREATMENT MARKET SIZE, BY DRUG, 2018-2024 (USD MILLION)
TABLE 138. AMERICAS NEUROPATHY PAIN TREATMENT MARKET SIZE, BY DRUG, 2025-2030 (USD MILLION)
TABLE 139. AMERICAS NEUROPATHY PAIN TREATMENT MARKET SIZE, BY ANALGESICS, 2018-2024 (USD MILLION)
TABLE 140. AMERICAS NEUROPATHY PAIN TREATMENT MARKET SIZE, BY ANALGESICS, 2025-2030 (USD MILLION)
TABLE 141. AMERICAS NEUROPATHY PAIN TREATMENT MARKET SIZE, BY ANTICONVULSANTS, 2018-2024 (USD MILLION)
TABLE 142. AMERICAS NEUROPATHY PAIN TREATMENT MARKET SIZE, BY ANTICONVULSANTS, 2025-2030 (USD MILLION)
TABLE 143. AMERICAS NEUROPATHY PAIN TREATMENT MARKET SIZE, BY ANTIDEPRESSANTS, 2018-2024 (USD MILLION)
TABLE 144. AMERICAS NEUROPATHY PAIN TREATMENT MARKET SIZE, BY ANTIDEPRESSANTS, 2025-2030 (USD MILLION)
TABLE 145. AMERICAS NEUROPATHY PAIN TREATMENT MARKET SIZE, BY TOPICAL AGENTS, 2018-2024 (USD MILLION)
TABLE 146. AMERICAS NEUROPATHY PAIN TREATMENT MARKET SIZE, BY TOPICAL AGENTS, 2025-2030 (USD MILLION)
TABLE 147. AMERICAS NEUROPATHY PAIN TREATMENT MARKET SIZE, BY THERAPY, 2018-2024 (USD MILLION)
TABLE 148. AMERICAS NEUROPATHY PAIN TREATMENT MARKET SIZE, BY THERAPY, 2025-2030 (USD MILLION)
TABLE 149. AMERICAS NEUROPATHY PAIN TREATMENT MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2024 (USD MILLION)
TABLE 150. AMERICAS NEUROPATHY PAIN TREATMENT MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2025-2030 (USD MILLION)
TABLE 151. AMERICAS NEUROPATHY PAIN TREATMENT MARKET SIZE, BY INJECTABLE, 2018-2024 (USD MILLION)
TABLE 152. AMERICAS NEUROPATHY PAIN TREATMENT MARKET SIZE, BY INJECTABLE, 2025-2030 (USD MILLION)
TABLE 153. AMERICAS NEUROPATHY PAIN TREATMENT MARKET SIZE, BY ORAL, 2018-2024 (USD MILLION)
TABLE 154. AMERICAS NEUROPATHY PAIN TREATMENT MARKET SIZE, BY ORAL, 2025-2030 (USD MILLION)
TABLE 155. AMERICAS NEUROPATHY PAIN TREATMENT MARKET SIZE, BY TOPICAL, 2018-2024 (USD MILLION)
TABLE 156. AMERICAS NEUROPATHY PAIN TREATMENT MARKET SIZE, BY TOPICAL, 2025-2030 (USD MILLION)
TABLE 157. AMERICAS NEUROPATHY PAIN TREATMENT MARKET SIZE, BY TRANSDERMAL, 2018-2024 (USD MILLION)
TABLE 158. AMERICAS NEUROPATHY PAIN TREATMENT MARKET SIZE, BY TRANSDERMAL, 2025-2030 (USD MILLION)
TABLE 159. AMERICAS NEUROPATHY PAIN TREATMENT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 160. AMERICAS NEUROPATHY PAIN TREATMENT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 161. AMERICAS NEUROPATHY PAIN TREATMENT MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 162. AMERICAS NEUROPATHY PAIN TREATMENT MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 163. AMERICAS NEUROPATHY PAIN TREATMENT MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
TABLE 164. AMERICAS NEUROPATHY PAIN TREATMENT MARKET SIZE, BY COUNTRY, 2025-2030 (USD MILLION)
TABLE 165. UNITED STATES NEUROPATHY PAIN TREATMENT MARKET SIZE, BY TREATMENT TYPE, 2018-2024 (USD MILLION)
TABLE 166. UNITED STATES NEUROPATHY PAIN TREATMENT MARKET SIZE, BY TREATMENT TYPE, 2025-2030 (USD MILLION)
TABLE 167. UNITED STATES NEUROPATHY PAIN TREATMENT MARKET SIZE, BY COMPLEMENTARY, 2018-2024 (USD MILLION)
TABLE 168. UNITED STATES NEUROPATHY PAIN TREATMENT MARKET SIZE, BY COMPLEMENTARY, 2025-2030 (USD MILLION)
TABLE 169. UNITED STATES NEUROPATHY PAIN TREATMENT MARKET SIZE, BY DEVICE, 2018-2024 (USD MILLION)
TABLE 170. UNITED STATES NEUROPATHY PAIN TREATMENT MARKET SIZE, BY DEVICE, 2025-2030 (USD MILLION)
TABLE 171. UNITED STATES NEUROPATHY PAIN TREATMENT MARKET SIZE, BY NEUROMODULATION, 2018-2024 (USD MILLION)
TABLE 172. UNITED STATES NEUROPATHY PAIN TREATMENT MARKET SIZE, BY NEUROMODULATION, 2025-2030 (USD MILLION)
TABLE 173. UNITED STATES NEUROPATHY PAIN TREATMENT MARKET SIZE, BY DRUG, 2018-2024 (USD MILLION)
TABLE 174. UNITED STATES NEUROPATHY PAIN TREATMENT MARKET SIZE, BY DRUG, 2025-2030 (USD MILLION)
TABLE 175. UNITED STATES NEUROPATHY PAIN TREATMENT MARKET SIZE, BY ANALGESICS, 2018-2024 (USD MILLION)
TABLE 176. UNITED STATES NEUROPATHY PAIN TREATMENT MARKET SIZE, BY ANALGESICS, 2025-2030 (USD MILLION)
TABLE 177. UNITED STATES NEUROPATHY PAIN TREATMENT MARKET SIZE, BY ANTICONVULSANTS, 2018-2024 (USD MILLION)
TABLE 178. UNITED STATES NEUROPATHY PAIN TREATMENT MARKET SIZE, BY ANTICONVULSANTS, 2025-2030 (USD MILLION)
TABLE 179. UNITED STATES NEUROPATHY PAIN TREATMENT MARKET SIZE, BY ANTIDEPRESSANTS, 2018-2024 (USD MILLION)
TABLE 180. UNITED STATES NEUROPATHY PAIN TREATMENT MARKET SIZE, BY ANTIDEPRESSANTS, 2025-2030 (USD MILLION)
TABLE 181. UNITED STATES NEUROPATHY PAIN TREATMENT MARKET SIZE, BY TOPICAL AGENTS, 2018-2024 (USD MILLION)
TABLE 182. UNITED STATES NEUROPATHY PAIN TREATMENT MARKET SIZE, BY TOPICAL AGENTS, 2025-2030 (USD MILLION)
TABLE 183. UNITED STATES NEUROPATHY PAIN TREATMENT MARKET SIZE, BY THERAPY, 2018-2024 (USD MILLION)
TABLE 184. UNITED STATES NEUROPATHY PAIN TREATMENT MARKET SIZE, BY THERAPY, 2025-2030 (USD MILLION)
TABLE 185. UNITED STATES NEUROPATHY PAIN TREATMENT MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2024 (USD MILLION)
TABLE 186. UNITED STATES NEUROPATHY PAIN TREATMENT MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2025-2030 (USD MILLION)
TABLE 187. UNITED STATES NEUROPATHY PAIN TREATMENT MARKET SIZE, BY INJECTABLE, 2018-2024 (USD MILLION)
TABLE 188. UNITED STATES NEUROPATHY PAIN TREATMENT MARKET SIZE, BY INJECTABLE, 2025-2030 (USD MILLION)
TABLE 189. UNITED STATES NEUROPATHY PAIN TREATMENT MARKET SIZE, BY ORAL, 2018-2024 (USD MILLION)
TABLE 190. UNITED STATES NEUROPATHY PAIN TREATMENT MARKET SIZE, BY ORAL, 2025-2030 (USD MILLION)
TABLE 191. UNITED STATES NEUROPATHY PAIN TREATMENT MARKET SIZE, BY TOPICAL, 2018-2024 (USD MILLION)
TABLE 192. UNITED STATES NEUROPATHY PAIN TREATMENT MARKET SIZE, BY TOPICAL, 2025-2030 (USD MILLION)
TABLE 193. UNITED STATES NEUROPATHY PAIN TREATMENT MARKET SIZE, BY TRANSDERMAL, 2018-2024 (USD MILLION)
TABLE 194. UNITED STATES NEUROPATHY PAIN TREATMENT MARKET SIZE, BY TRANSDERMAL, 2025-2030 (USD MILLION)
TABLE 195. UNITED STATES NEUROPATHY PAIN TREATMENT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 196. UNITED STATES NEUROPATHY PAIN TREATMENT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 197. UNITED STATES NEUROPATHY PAIN TREATMENT MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 198. UNITED STATES NEUROPATHY PAIN TREATMENT MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 199. UNITED STATES NEUROPATHY PAIN TREATMENT MARKET SIZE, BY STATE, 2018-2024 (USD MILLION)
TABLE 200. UNITED STATES NEUROPATHY PAIN TREATMENT MARKET SIZE, BY STATE, 2025-2030 (USD MILLION)
TABLE 201. CANADA NEUROPATHY PAIN TREATMENT MARKET SIZE, BY TREATMENT TYPE, 2018-2024 (USD MILLION)
TABLE 202. CANADA NEUROPATHY PAIN TREATMENT MARKET SIZE, BY TREATMENT TYPE, 2025-2030 (USD MILLION)
TABLE 203. CANADA NEUROPATHY PAIN TREATMENT MARKET SIZE, BY COMPLEMENTARY, 2018-2024 (USD MILLION)
TABLE 204. CANADA NEUROPATHY PAIN TREATMENT MARKET SIZE, BY COMPLEMENTARY, 2025-2030 (USD MILLION)
TABLE 205. CANADA NEUROPATHY PAIN TREATMENT MARKET SIZE, BY DEVICE, 2018-2024 (USD MILLION)
TABLE 206. CANADA NEUROPATHY PAIN TREATMENT MARKET SIZE, BY DEVICE, 2025-2030 (USD MILLION)
TABLE 207. CANADA NEUROPATHY PAIN TREATMENT MARKET SIZE, BY NEUROMODULATION, 2018-2024 (USD MILLION)
TABLE 208. CANADA NEUROPATHY PAIN TREATMENT MARKET SIZE, BY NEUROMODULATION, 2025-2030 (USD MILLION)
TABLE 209. CANADA NEUROPATHY PAIN TREATMENT MARKET SIZE, BY DRUG, 2018-2024 (USD MILLION)
TABLE 210. CANADA NEUROPATHY PAIN TREATMENT MARKET SIZE, BY DRUG, 2025-2030 (USD MILLION)
TABLE 211. CANADA NEUROPATHY PAIN TREATMENT MARKET SIZE, BY ANALGESICS, 2018-2024 (USD MILLION)
TABLE 212. CANADA NEUROPATHY PAIN TREATMENT MARKET SIZE, BY ANALGESICS, 2025-2030 (USD MILLION)
TABLE 213. CANADA NEUROPATHY PAIN TREATMENT MARKET SIZE, BY ANTICONVULSANTS, 2018-2024 (USD MILLION)
TABLE 214. CANADA NEUROPATHY PAIN TREATMENT MARKET SIZE, BY ANTICONVULSANTS, 2025-2030 (USD MILLION)
TABLE 215. CANADA NEUROPATHY PAIN TREATMENT MARKET SIZE, BY ANTIDEPRESSANTS, 2018-2024 (USD MILLION)
TABLE 216. CANADA NEUROPATHY PAIN TREATMENT MARKET SIZE, BY ANTIDEPRESSANTS, 2025-2030 (USD MILLION)
TABLE 217. CANADA NEUROPATHY PAIN TREATMENT MARKET SIZE, BY TOPICAL AGENTS, 2018-2024 (USD MILLION)
TABLE 218. CANADA NEUROPATHY PAIN TREATMENT MARKET SIZE, BY TOPICAL AGENTS, 2025-2030 (USD MILLION)
TABLE 219. CANADA NEUROPATHY PAIN TREATMENT MARKET SIZE, BY THERAPY, 2018-2024 (USD MILLION)
TABLE 220. CANADA NEUROPATHY PAIN TREATMENT MARKET SIZE, BY THERAPY, 2025-2030 (USD MILLION)
TABLE 221. CANADA NEUROPATHY PAIN TREATMENT MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2024 (USD MILLION)
TABLE 222. CANADA NEUROPATHY PAIN TREATMENT MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2025-2030 (USD MILLION)
TABLE 223. CANADA NEUROPATHY PAIN TREATMENT MARKET SIZE, BY INJECTABLE, 2018-2024 (USD MILLION)
TABLE 224. CANADA NEUROPATHY PAIN TREATMENT MARKET SIZE, BY INJECTABLE, 2025-2030 (USD MILLION)
TABLE 225. CANADA NEUROPATHY PAIN TREATMENT MARKET SIZE, BY ORAL, 2018-2024 (USD MILLION)
TABLE 226. CANADA NEUROPATHY PAIN TREATMENT MARKET SIZE, BY ORAL, 2025-2030 (USD MILLION)
TABLE 227. CANADA NEUROPATHY PAIN TREATMENT MARKET SIZE, BY TOPICAL, 2018-2024 (USD MILLION)
TABLE 228. CANADA NEUROPATHY PAIN TREATMENT MARKET SIZE, BY TOPICAL, 2025-2030 (USD MILLION)
TABLE 229. CANADA NEUROPATHY PAIN TREATMENT MARKET SIZE, BY TRANSDERMAL, 2018-2024 (USD MILLION)
TABLE 230. CANADA NEUROPATHY PAIN TREATMENT MARKET SIZE, BY TRANSDERMAL, 2025-2030 (USD MILLION)
TABLE 231. CANADA NEUROPATHY PAIN TREATMENT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 232. CANADA NEUROPATHY PAIN TREATMENT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 233. CANADA NEUROPATHY PAIN TREATMENT MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 234. CANADA NEUROPATHY PAIN TREATMENT MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 235. MEXICO NEUROPATHY PAIN TREATMENT MARKET SIZE, BY TREATMENT TYPE, 2018-2024 (USD MILLION)
TABLE 236. MEXICO NEUROPATHY PAIN TREATMENT MARKET SIZE, BY TREATMENT TYPE, 2025-2030 (USD MILLION)
TABLE 237. MEXICO NEUROPATHY PAIN TREATMENT MARKET SIZE, BY COMPLEMENTARY, 2018-2024 (USD MILLION)
TABLE 238. MEXICO NEUROPATHY PAIN TREATMENT MARKET SIZE, BY COMPLEMENTARY, 2025-2030 (USD MILLION)
TABLE 239. MEXICO NEUROPATHY PAIN TREATMENT MARKET SIZE, BY DEVICE, 2018-2024 (USD MILLION)
TABLE 240. MEXICO NEUROPATHY PAIN TREATMENT MARKET SIZE, BY DEVICE, 2025-2030 (USD MILLION)
TABLE 241. MEXICO NEUROPATHY PAIN TREATMENT MARKET SIZE, BY NEUROMODULATION, 2018-2024 (USD MILLION)
TABLE 242. MEXICO NEUROPATHY PAIN TREATMENT MARKET SIZE, BY NEUROMODULATION, 2025-2030 (USD MILLION)
TABLE 243. MEXICO NEUROPATHY PAIN TREATMENT MARKET SIZE, BY DRUG, 2018-2024 (USD MILLION)
TABLE 244. MEXICO NEUROPATHY PAIN TREATMENT MARKET SIZE, BY DRUG, 2025-2030 (USD MILLION)
TABLE 245. MEXICO NEUROPATHY PAIN TREATMENT MARKET SIZE, BY ANALGESICS, 2018-2024 (USD MILLION)
TABLE 246. MEXICO NEUROPATHY PAIN TREATMENT MARKET SIZE, BY ANALGESICS, 2025-2030 (USD MILLION)
TABLE 247. MEXICO NEUROPATHY PAIN TREATMENT MARKET SIZE, BY ANTICONVULSANTS, 2018-2024 (USD MILLION)
TABLE 248. MEXICO NEUROPATHY PAIN TREATMENT MARKET SIZE, BY ANTICONVULSANTS, 2025-2030 (USD MILLION)
TABLE 249. MEXICO NEUROPATHY PAIN TREATMENT MARKET SIZE, BY ANTIDEPRESSANTS, 2018-2024 (USD MILLION)
TABLE 250. MEXICO NEUROPATHY PAIN TREATMENT MARKET SIZE, BY ANTIDEPRESSANTS, 2025-2030 (USD MILLION)
TABLE 251. MEXICO NEUROPATHY PAIN TREATMENT MARKET SIZE, BY TOPICAL AGENTS, 2018-2024 (USD MILLION)
TABLE 252. MEXICO NEUROPATHY PAIN TREATMENT MARKET SIZE, BY TOPICAL AGENTS, 2025-2030 (USD MILLION)
TABLE 253. MEXICO NEUROPATHY PAIN TREATMENT MARKET SIZE, BY THERAPY, 2018-2024 (USD MILLION)
TABLE 254. MEXICO NEUROPATHY PAIN TREATMENT MARKET SIZE, BY THERAPY, 2025-2030 (USD MILLION)
TABLE 255. MEXICO NEUROPATHY PAIN TREATMENT MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2024 (USD MILLION)
TABLE 256. MEXICO NEUROPATHY PAIN TREATMENT MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2025-2030 (USD MILLION)
TABLE 257. MEXICO NEUROPATHY PAIN TREATMENT MARKET SIZE, BY INJECTABLE, 2018-2024 (USD MILLION)
TABLE 258. MEXICO NEUROPATHY PAIN TREATMENT MARKET SIZE, BY INJECTABLE, 2025-2030 (USD MILLION)
TABLE 259. MEXICO NEUROPATHY PAIN TREATMENT MARKET SIZE, BY ORAL, 2018-2024 (USD MILLION)
TABLE 260. MEXICO NEUROPATHY PAIN TREATMENT MARKET SIZE, BY ORAL, 2025-2030 (USD MILLION)
TABLE 261. MEXICO NEUROPATHY PAIN TREATMENT MARKET SIZE, BY TOPICAL, 2018-2024 (USD MILLION)
TABLE 262. MEXICO NEUROPATHY PAIN TREATMENT MARKET SIZE, BY TOPICAL, 2025-2030 (USD MILLION)
TABLE 263. MEXICO NEUROPATHY PAIN TREATMENT MARKET SIZE, BY TRANSDERMAL, 2018-2024 (USD MILLION)
TABLE 264. MEXICO NEUROPATHY PAIN TREATMENT MARKET SIZE, BY TRANSDERMAL, 2025-2030 (USD MILLION)
TABLE 265. MEXICO NEUROPATHY PAIN TREATMENT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 266. MEXICO NEUROPATHY PAIN TREATMENT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 267. MEXICO NEUROPATHY PAIN TREATMENT MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 268. MEXICO NEUROPATHY PAIN TREATMENT MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 269. BRAZIL NEUROPATHY PAIN TREATMENT MARKET SIZE, BY TREATMENT TYPE, 2018-2024 (USD MILLION)
TABLE 270. BRAZIL NEUROPATHY PAIN TREATMENT MARKET SIZE, BY TREATMENT TYPE, 2025-2030 (USD MILLION)
TABLE 271. BRAZIL NEUROPATHY PAIN TREATMENT MARKET SIZE, BY COMPLEMENTARY, 2018-2024 (USD MILLION)
TABLE 272. BRAZIL NEUROPATHY PAIN TREATMENT MARKET SIZE, BY COMPLEMENTARY, 2025-2030 (USD MILLION)
TABLE 273. BRAZIL NEUROPATHY PAIN TREATMENT MARKET SIZE, BY DEVICE, 2018-2024 (USD MILLION)
TABLE 274. BRAZIL NEUROPATHY PAIN TREATMENT MARKET SIZE, BY DEVICE, 2025-2030 (USD MILLION)
TABLE 275. BRAZIL NEUROPATHY PAIN TREATMENT MARKET SIZE, BY NEUROMODULATION, 2018-2024 (USD MILLION)
TABLE 276. BRAZIL NEUROPATHY PAIN TREATMENT MARKET SIZE, BY NEUROMODULATION, 2025-2030 (USD MILLION)
TABLE 277. BRAZIL NEUROPATHY PAIN TREATMENT MARKET SIZE, BY DRUG, 2018-2024 (USD MILLION)
TABLE 278. BRAZIL NEUROPATHY PAIN TREATMENT MARKET SIZE, BY DRUG, 2025-2030 (USD MILLION)
TABLE 279. BRAZIL NEUROPATHY PAIN TREATMENT MARKET SIZE, BY ANALGESICS, 2018-2024 (USD MILLION)
TABLE 280. BRAZIL NEUROPATHY PAIN TREATMENT MARKET SIZE, BY ANALGESICS, 2025-2030 (USD MILLION)
TABLE 281. BRAZIL NEUROPATHY PAIN TREATMENT MARKET SIZE, BY ANTICONVULSANTS, 2018-2024 (USD MILLION)
TABLE 282. BRAZIL NEUROPATHY PAIN TREATMENT MARKET SIZE, BY ANTICONVULSANTS, 2025-2030 (USD MILLION)
TABLE 283. BRAZIL NEUROPATHY PAIN TREATMENT MARKET SIZE, BY ANTIDEPRESSANTS, 2018-2024 (USD MILLION)
TABLE 284. BRAZIL NEUROPATHY PAIN TREATMENT MARKET SIZE, BY ANTIDEPRESSANTS, 2025-2030 (USD MILLION)
TABLE 285. BRAZIL NEUROPATHY PAIN TREATMENT MARKET SIZE, BY TOPICAL AGENTS, 2018-2024 (USD MILLION)
TABLE 286. BRAZIL NEUROPATHY PAIN TREATMENT MARKET SIZE, BY TOPICAL AGENTS, 2025-2030 (USD MILLION)
TABLE 287. BRAZIL NEUROPATHY PAIN TREATMENT MARKET SIZE, BY THERAPY, 2018-2024 (USD MILLION)
TABLE 288. BRAZIL NEUROPATHY PAIN TREATMENT MARKET SIZE, BY THERAPY, 2025-2030 (USD MILLION)
TABLE 289. BRAZIL NEUROPATHY PAIN TREATMENT MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2024 (USD MILLION)
TABLE 290. BRAZIL NEUROPATHY PAIN TREATMENT MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2025-2030 (USD MILLION)
TABLE 291. BRAZIL NEUROPATHY PAIN TREATMENT MARKET SIZE, BY INJECTABLE, 2018-2024 (USD MILLION)
TABLE 292. BRAZIL NEUROPATHY PAIN TREATMENT MARKET SIZE, BY INJECTABLE, 2025-2030 (USD MILLION)
TABLE 293. BRAZIL NEUROPATHY PAIN TREATMENT MARKET SIZE, BY ORAL, 2018-2024 (USD MILLION)
TABLE 294. BRAZIL NEUROPATHY PAIN TREATMENT MARKET SIZE, BY ORAL, 2025-2030 (USD MILLION)
TABLE 295. BRAZIL NEUROPATHY PAIN TREATMENT MARKET SIZE, BY TOPICAL, 2018-2024 (USD MILLION)
TABLE 296. BRAZIL NEUROPATHY PAIN TREATMENT MARKET SIZE, BY TOPICAL, 2025-2030 (USD MILLION)
TABLE 297. BRAZIL NEUROPATHY PAIN TREATMENT MARKET SIZE, BY TRANSDERMAL, 2018-2024 (USD MILLION)
TABLE 298. BRAZIL NEUROPATHY PAIN TREATMENT MARKET SIZE, BY TRANSDERMAL, 2025-2030 (USD MILLION)
TABLE 299. BRAZIL NEUROPATHY PAIN TREATMENT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 300. BRAZIL NEUROPATHY PAIN TREATMENT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 301. BRAZIL NEUROPATHY PAIN TREATMENT MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 302. BRAZIL NEUROPATHY PAIN TREATMENT MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 303. ARGENTINA NEUROPATHY PAIN TREATMENT MARKET SIZE, BY TREATMENT TYPE, 2018-2024 (USD MILLION)
TABLE 304. ARGENTINA NEUROPATHY PAIN TREATMENT MARKET SIZE, BY TREATMENT TYPE, 2025-2030 (USD MILLION)
TABLE 305. ARGENTINA NEUROPATHY PAIN TREATMENT MARKET SIZE, BY COMPLEMENTARY, 2018-2024 (USD MILLION)
TABLE 306. ARGENTINA NEUROPATHY PAIN TREATMENT MARKET SIZE, BY COMPLEMENTARY, 2025-2030 (USD MILLION)
TABLE 307. ARGENTINA NEUROPATHY PAIN TREATMENT MARKET SIZE, BY DEVICE, 2018-2024 (USD MILLION)
TABLE 308. ARGENTINA NEUROPATHY PAIN TREATMENT MARKET SIZE, BY DEVICE, 2025-2030 (USD MILLION)
TABLE 309. ARGENTINA NEUROPATHY PAIN TREATMENT MARKET SIZE, BY NEUROMODULATION, 2018-2024 (USD MILLION)
TABLE 310. ARGENTINA NEUROPATHY PAIN TREATMENT MARKET SIZE, BY NEUROMODULATION, 2025-2030 (USD MILLION)
TABLE 311. ARGENTINA NEUROPATHY PAIN TREATMENT MARKET SIZE, BY DRUG, 2018-2024 (USD MILLION)
TABLE 312. ARGENTINA NEUROPATHY PAIN TREATMENT MARKET SIZE, BY DRUG, 2025-2030 (USD MILLION)
TABLE 313. ARGENTINA NEUROPATHY PAIN TREATMENT MARKET SIZE, BY ANALGESICS, 2018-2024 (USD MILLION)
TABLE 314. ARGENTINA NEUROPATHY PAIN TREATMENT MARKET SIZE, BY ANALGESICS, 2025-2030 (USD MILLION)
TABLE 315. ARGENTINA NEUROPATHY PAIN TREATMENT MARKET SIZE, BY ANTICONVULSANTS, 2018-2024 (USD MILLION)
TABLE 316. ARGENTINA NEUROPATHY PAIN TREATMENT MARKET SIZE, BY ANTICONVULSANTS, 2025-2030 (USD MILLION)
TABLE 317. ARGENTINA NEUROPATHY PAIN TREATMENT MARKET SIZE, BY ANTIDEPRESSANTS, 2018-2024 (USD MILLION)
TABLE 318. ARGENTINA NEUROPATHY PAIN TREATMENT MARKET SIZE, BY ANTIDEPRESSANTS, 2025-2030 (USD MILLION)
TABLE 319. ARGENTINA NEUROPATHY PAIN TREATMENT MARKET SIZE, BY TOPICAL AGENTS, 2018-2024 (USD MILLION)
TABLE 320. ARGENTINA NEUROPATHY PAIN TREATMENT MARKET SIZE, BY TOPICAL AGENTS, 2025-2030 (USD MILLION)
TABLE 321. ARGENTINA NEUROPATHY PAIN TREATMENT MARKET SIZE, BY THERAPY, 2018-2024 (USD MILLION)
TABLE 322. ARGENTINA NEUROPATHY PAIN TREATMENT MARKET SIZE, BY THERAPY, 2025-2030 (USD MILLION)
TABLE 323. ARGENTINA NEUROPATHY PAIN TREATMENT MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2024 (USD MILLION)
TABLE 324. ARGENTINA NEUROPATHY PAIN TREATMENT MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2025-2030 (USD MILLION)
TABLE 325. ARGENTINA NEUROPATHY PAIN TREATMENT MARKET SIZE, BY INJECTABLE, 2018-2024 (USD MILL

Samples

Loading
LOADING...

Companies Mentioned

The companies profiled in this Neuropathy Pain Treatment market report include:
  • Pfizer Inc.
  • Eli Lilly and Company
  • Teva Pharmaceutical Industries Ltd.
  • Viatris Inc.
  • Endo International plc
  • Grünenthal GmbH
  • Novartis AG
  • Astellas Pharma Inc.
  • Sun Pharmaceutical Industries Ltd.
  • Sandoz International GmbH

Table Information

Report AttributeDetails
No. of Pages186
PublishedAugust 2025
Forecast Period2025 - 2030
Estimated Market Value ( USD ) in 2025 $ 9.64 Billion
Forecasted Market Value ( USD ) by 2030 $ 16.63 Billion
Compound Annual Growth Rate11.6%
Regions CoveredGlobal
No. of Companies Mentioned11

Related Topics

Related Reports

Diabetic Neuropathy Market by Drug Class (Anticonvulsants, Opioids, Snris), Route Of Administration (Oral, Parenteral, Topical), Distribution Channel, End User - Global Forecast 2025-2030 - Product Image

Diabetic Neuropathy Market by Drug Class (Anticonvulsants, Opioids, Snris), Route Of Administration (Oral, Parenteral, Topical), Distribution Channel, End User - Global Forecast 2025-2030

  • Report
  • 182 Pages
  • Global
From
Diabetic Neuropathic Pain Market Report and Forecast 2025-2034 - Product Image

Diabetic Neuropathic Pain Market Report and Forecast 2025-2034

  • Report
  • 400 Pages
  • Global
From
Neuropathic Pain Drug Market by Product Type (Anticonvulsants, Antidepressants, Opioids), Route Of Administration (Intravenous, Oral, Topical), Indication, Distribution Channel - Global Forecast 2025-2030 - Product Image

Neuropathic Pain Drug Market by Product Type (Anticonvulsants, Antidepressants, Opioids), Route Of Administration (Intravenous, Oral, Topical), Indication, Distribution Channel - Global Forecast 2025-2030

  • Report
  • 187 Pages
  • Global
From
Diabetic Neuropathic Pain - Global Strategic Business Report - Product Image

Diabetic Neuropathic Pain - Global Strategic Business Report

  • Report
  • 384 Pages
  • Global
From
Diabetic Neuropathic Pain Market - Global Industry Size, Share, Trends, Opportunity, and Forecast, 2020-2030F - Product Image

Diabetic Neuropathic Pain Market - Global Industry Size, Share, Trends, Opportunity, and Forecast, 2020-2030F

  • Report
  • 185 Pages
  • Global
From

About the Neuropathy Pain Drug Market

The Neuropathy Pain Drug market is a subset of the Central Nervous System Drugs market, which includes drugs used to treat neurological disorders. Neuropathy Pain Drugs are used to treat the pain associated with peripheral neuropathy, a condition caused by damage to the peripheral nervous system. These drugs are typically prescribed to patients with diabetes, HIV, and chemotherapy-induced neuropathy. Commonly prescribed Neuropathy Pain Drugs include anticonvulsants, antidepressants, and opioids. The Neuropathy Pain Drug market is highly competitive, with many companies offering a variety of drugs. Some of the major players in the market include Pfizer, GlaxoSmithKline, Novartis, Johnson & Johnson, and Merck & Co. Other companies in the market include AbbVie, AstraZeneca, Eli Lilly, and Teva Pharmaceuticals. Show Less Read more

Copyright © 2002-2025 Research and Markets. All Rights Reserved.